DekaBank Deutsche Girozentrale’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Hold |
60,000
| – | – | ﹤0.01% | 784 |
|
|
2025
Q1 | $1.48M | Hold |
60,000
| – | – | ﹤0.01% | 780 |
|
|
2024
Q4 | $1.4M | Hold |
60,000
| – | – | ﹤0.01% | 812 |
|
|
2024
Q3 | $1.48M | Hold |
60,000
| – | – | ﹤0.01% | 819 |
|
|
2024
Q2 | $1.48M | Hold |
60,000
| – | – | ﹤0.01% | 813 |
|
|
2024
Q1 | $1.48M | Hold |
60,000
| – | – | ﹤0.01% | 807 |
|
|
2023
Q4 | $560K | Hold |
60,000
| – | – | ﹤0.01% | 1013 |
|
|
2023
Q3 | $394K | Hold |
60,000
| – | – | ﹤0.01% | 1074 |
|
|
2023
Q2 | $665K | Buy |
60,000
+36,000
| +150% | +$399K | ﹤0.01% | 969 |
|
|
2023
Q1 | $403K | Hold |
24,000
| – | – | ﹤0.01% | 1055 |
|
|
2022
Q4 | $544K | Buy |
+24,000
| New | +$544K | ﹤0.01% | 1016 |
|
|
2022
Q2 | – | Sell |
-15,800
| Closed | -$285K | – | 1417 |
|
|
2022
Q1 | $285K | Buy |
15,800
+1,400
| +10% | +$25.3K | ﹤0.01% | 1157 |
|
|
2021
Q4 | $334K | Buy |
14,400
+400
| +3% | +$9.28K | ﹤0.01% | 1178 |
|
|
2021
Q3 | $324K | Hold |
14,000
| – | – | ﹤0.01% | 1125 |
|
|
2021
Q2 | $320K | Hold |
14,000
| – | – | ﹤0.01% | 1136 |
|
|
2021
Q1 | $284K | Hold |
14,000
| – | – | ﹤0.01% | 1124 |
|
|
2020
Q4 | $384K | Buy |
+14,000
| New | +$384K | ﹤0.01% | 1077 |
|